About AlphaCore Pharma
AlphaCore Pharma is a company based in Ann Arbor (United States) founded in 2007 was acquired by MedImmune in April 2013. It operates as a B2B. AlphaCore Pharma operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AlphaCore Pharma
Detailed funding history for AlphaCore Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AlphaCore Pharma
AlphaCore Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MedImmune.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biologic R&D for oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases
|
Locked | Locked | Locked |
Investor details for AlphaCore Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AlphaCore Pharma
Investment portfolio details for AlphaCore Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AlphaCore Pharma
Detailed financials for AlphaCore Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alphacore Pharma Comparisons
Peer comparison for AlphaCore Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AlphaCore Pharma
AlphaCore Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| Locked | Locked | Locked |
Specialized drugs are developed for genetic heart diseases.
|
|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
|
| Locked | Locked | Locked |
Provider of tools for the analysis of RNA structures
|
|
| Locked | Locked | Locked |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| Locked | Locked | Locked |
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
Detailed competitors of AlphaCore Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alphacore Pharma
Complete news archive for AlphaCore Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AlphaCore Pharma
AlphaCore Pharma was founded in 2007.
AlphaCore Pharma is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
AlphaCore Pharma, based in Ann Arbor, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and protein treatments. Develops protein therapeutics for treating cardiovascular diseases like atherosclerosis. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
AlphaCore Pharma's top competitors include Tenaya Therapeutics, Cellino and MyoKardia.
AlphaCore Pharma has 1 investor. Key investors include MedImmune.